China Tian Yuan Healthcare Group Limited
HKEX:0557.HK
0.83 (HKD) • At close July 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 45.23 | 54.216 | 94.588 | 56.34 | 70.548 | 171.556 | 175.28 | 100.654 | 92.207 | 100.13 | 102.838 | 135.085 | 109.336 | 83.686 | 65.27 | 122.479 | 105.254 | 79.01 | 84.518 | 72.147 | 84.863 | 77.811 | 98.197 |
| Cost of Revenue
| 20.073 | 19.391 | 23.281 | 18.766 | 17.873 | 22.032 | 23.228 | 19.498 | 18.175 | 18.457 | 18.981 | 33.034 | 33.901 | 13.56 | 18.13 | 34.647 | 22.189 | 8.609 | 21.321 | 22.502 | 20.135 | 18.43 | 24.599 |
| Gross Profit
| 25.157 | 34.825 | 71.307 | 37.574 | 52.675 | 149.524 | 152.052 | 81.156 | 74.032 | 81.673 | 83.857 | 102.051 | 75.435 | 70.126 | 47.14 | 87.832 | 83.065 | 70.401 | 63.197 | 49.645 | 64.728 | 59.381 | 73.598 |
| Gross Profit Ratio
| 0.556 | 0.642 | 0.754 | 0.667 | 0.747 | 0.872 | 0.867 | 0.806 | 0.803 | 0.816 | 0.815 | 0.755 | 0.69 | 0.838 | 0.722 | 0.717 | 0.789 | 0.891 | 0.748 | 0.688 | 0.763 | 0.763 | 0.749 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0.313 | 0.626 | 0.919 | 2.371 | 2.366 | 2.368 | 2.377 | 1.974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 40.752 | 56.633 | 90.031 | 84.172 | 72.508 | 192.5 | 175.344 | 119.847 | 96.72 | 105.383 | 92.612 | 115.215 | 86.533 | 67.198 | 44.516 | 74.664 | 56.627 | 42.537 | 44.02 | 48.21 | 49.101 | 70.873 | 95.446 |
| Selling & Marketing Expenses
| 7.225 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.977 | 56.633 | 90.031 | 84.172 | 72.508 | 192.5 | 175.344 | 119.847 | 96.72 | 105.383 | 92.612 | 115.215 | 86.533 | 67.198 | 44.516 | 74.664 | 56.627 | 42.537 | 44.02 | 48.21 | 49.101 | 70.873 | 95.446 |
| Other Expenses
| 1.94 | 0.8 | -1.299 | -3.24 | 76.188 | 0.022 | 0.544 | 0 | 0.721 | 4.344 | 0.025 | 0 | 0.022 | 7.474 | -49.337 | 143.271 | 5.265 | 0 | 11.807 | -25.919 | -17.978 | -30.205 | 16.257 |
| Operating Expenses
| 47.977 | 57.433 | 88.732 | 80.932 | 148.696 | 192.5 | 175.344 | 119.847 | 96.72 | 105.383 | 92.612 | 115.215 | 86.555 | 74.672 | -4.821 | 217.935 | 61.892 | 42.537 | 55.827 | 22.291 | 31.123 | 40.668 | 111.703 |
| Operating Income
| -22.82 | -26.974 | -13.796 | -35.375 | -137.254 | -42.976 | -23.292 | -69.403 | -48.004 | -24.269 | 14.806 | 3.12 | -11.12 | -5.267 | 51.961 | -130.103 | 21.173 | 27.864 | 7.37 | 27.354 | 33.605 | 18.713 | -38.105 |
| Operating Income Ratio
| -0.505 | -0.498 | -0.146 | -0.628 | -1.946 | -0.251 | -0.133 | -0.69 | -0.521 | -0.242 | 0.144 | 0.023 | -0.102 | -0.063 | 0.796 | -1.062 | 0.201 | 0.353 | 0.087 | 0.379 | 0.396 | 0.24 | -0.388 |
| Total Other Income Expenses Net
| -5.593 | -13.375 | -5.267 | -90.472 | -52.551 | 3.304 | 24.194 | -12.052 | -25.648 | 0.232 | 16.874 | 13.4 | -30.646 | -0.721 | -0.544 | -1.065 | -2.478 | 46.717 | 0 | 0 | 0 | 0 | -0.016 |
| Income Before Tax
| -28.413 | -40.349 | -19.063 | -125.847 | -189.805 | -39.672 | 0.902 | -50.743 | -48.336 | -23.478 | 16.304 | 0.236 | -41.766 | -5.267 | 51.417 | -131.168 | 18.695 | 74.581 | 7.37 | 27.354 | 33.605 | 18.713 | -38.121 |
| Income Before Tax Ratio
| -0.628 | -0.744 | -0.202 | -2.234 | -2.69 | -0.231 | 0.005 | -0.504 | -0.524 | -0.234 | 0.159 | 0.002 | -0.382 | -0.063 | 0.788 | -1.071 | 0.178 | 0.944 | 0.087 | 0.379 | 0.396 | 0.24 | -0.388 |
| Income Tax Expense
| -1.821 | -1.897 | 3.058 | -15.812 | 0.219 | 0.375 | 2.33 | 10.556 | 13.638 | -4.964 | 0.442 | -2.528 | -1.419 | -7.302 | 0.119 | 7.51 | 2.488 | -20.871 | 1.978 | -0.015 | 0.499 | 0.376 | 0.17 |
| Net Income
| -15.484 | -38.452 | -22.121 | -110.035 | -190.024 | -40.047 | -1.428 | -57.55 | -55.067 | -18.978 | 17.169 | 7.064 | -31.231 | 8.994 | 55.865 | -138.991 | 14.091 | 95.452 | 5.392 | 26.519 | 33.106 | 20.489 | -35.665 |
| Net Income Ratio
| -0.342 | -0.709 | -0.234 | -1.953 | -2.694 | -0.233 | -0.008 | -0.572 | -0.597 | -0.19 | 0.167 | 0.052 | -0.286 | 0.107 | 0.856 | -1.135 | 0.134 | 1.208 | 0.064 | 0.368 | 0.39 | 0.263 | -0.363 |
| EPS
| -0.039 | -0.096 | -0.055 | -0.28 | -0.48 | -0.1 | -0.004 | -0.15 | -0.14 | -0.05 | 0.045 | 0.019 | -0.082 | 0.024 | 0.15 | -0.36 | 0.037 | 0.24 | 0.014 | 0.69 | 0.086 | 0.054 | -0.093 |
| EPS Diluted
| -0.039 | -0.096 | -0.055 | -0.28 | -0.48 | -0.1 | -0.004 | -0.15 | -0.14 | -0.05 | 0.045 | 0.019 | -0.082 | 0.024 | 0.15 | -0.36 | 0.037 | 0.24 | 0.014 | 0.69 | 0.086 | 0.054 | -0.093 |
| EBITDA
| -13.744 | -17.445 | -1.927 | -14.233 | -114.6 | -21.115 | -8.451 | -26.573 | -23.471 | -23.155 | 4.735 | -1.013 | -32.756 | -1.216 | 54.237 | -126.608 | 23.443 | 27.864 | 8.79 | 29.054 | 36.329 | 22.156 | -34.443 |
| EBITDA Ratio
| -0.304 | -0.322 | -0.02 | -0.253 | -1.624 | -0.123 | -0.048 | -0.264 | -0.255 | -0.231 | 0.046 | -0.007 | -0.3 | -0.015 | 0.831 | -1.034 | 0.223 | 0.353 | 0.104 | 0.403 | 0.428 | 0.285 | -0.351 |